PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES

por Zeidan, A., Divino, V., DeKoven, M., Shah, D., Wang, E., Bey, D., Salimi, T., Epstein, R.
Publicado 2022